Neuroscience
Positron Emission Tomography
100%
In Vivo
65%
Serotonin Transporter
64%
Positron Emission Tomography
49%
DASB
36%
Dementia Praecox
28%
Radioligand
26%
Translocator Protein
25%
Antipsychotic
24%
Serotonin
24%
Fluorine-18
21%
Striatum
21%
Molecular Imaging
18%
Propylnorapomorphine
18%
Eicosanoid Receptor
17%
Anterior Cingulate Cortex
17%
Neuroreceptor
15%
Levoamphetamine
15%
Tryptophan
14%
Single-Photon Emission Computed Tomography
14%
Receptor Occupancy
12%
Serotonergic
11%
Cerebellum
11%
Major Depressive Disorder
10%
Dopamine Receptor D2
10%
Dopaminergic Transmission
9%
Ventral Striatum
9%
Decision-Making
9%
Obsessive-Compulsive Disorder
9%
Multiple Sclerosis
9%
Nuclear Magnetic Resonance Spectroscopy
9%
Periaqueductal Gray
9%
Κ-opioid receptor
9%
Selective Serotonin Reuptake Inhibitor
9%
MDMA
9%
Bipolar Depression
9%
Anxiety Disorder
9%
Precuneus
9%
Endorphin
9%
Brain Imaging
9%
Electrical Brain Stimulation
9%
Brain Positron Emission Tomography
9%
Glutamic Acid
9%
Raclopride
8%
Brainstem
7%
Atypical Antipsychotic
6%
Hippocampus
6%
Prefrontal Cortex
6%
Impulsivity
6%
Negative Syndrome
6%
Medicine and Dentistry
Positron Emission Tomography
45%
Mitochondrial Membrane Transport Protein
18%
Positron Emission Tomography
18%
Carbon 11
15%
DASB
12%
Anterior Cingulate
12%
Diseases
11%
Drug Therapy
11%
Major Depressive Episode
10%
Treatment of Schizophrenia
10%
Neuroinflammation
10%
Depression
9%
Serotonin Transporter
9%
Volinanserin
9%
5-HT Receptors
9%
Brain Positron Emission Tomography
9%
Molecular Imaging
9%
Psychopharmacology
9%
Antidepressant
9%
Cingulate Cortex
7%
Meta-Analysis
6%
Radioligand
5%
Brainstem
5%
Single-Photon Emission Computed Tomography
5%